Risk Stratification in Multiple Myeloma: Putting the Pieces Together
November 7, 2015
Learning Objectives
- Describe updated recommendations for the diagnosis and risk-stratified treatment of Multiple Myeloma (MM)
- Discuss new novel agents for the treatment of MM including indications, common adverse events, monitoring and support of the patient receiving these treatments
- Implement effective clinical strategies for minimizing toxicity
- Utilize practical strategies for enhancing patients’ adherence to treatment
United States
Craig B. Reeder, MD
Angela Mayo, PA
Available Credit
- 1.00 AANP
- 0.67 Pharmacology
- 1.00 ACPE
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance
- 1.00 ANCC